Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by:...

66
Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing Original PPT by: Professor Pat Woodbery, ARNP, CS

Transcript of Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by:...

Page 1: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Antidiabetic and Hypoglycemic Agents

Lilley Pharmacology Text: Chapter 30

Original Text modified by:Anita A. Kovalsky, R.N., M.N.Ed.,Professor of Nursing

Original PPT by: Professor Pat Woodbery, ARNP, CS

Page 2: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Syllabus Assistive Guides:

• Prototype Drugs: Antidiabetic: pg. 33

• Learning Questions: pg. 34

Page 3: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Review of Glossary Terms:Lilley pg. 468

• Diabetes mellitus• Diabetic ketoacidosis• Glucagon• Glucose• Glycogen• Glycogenolysis• Hyperglycemia• Hypoglygemia

• Insulin• Ketones• Neuuropathy• Nephropathy• Polydipsia• Polyphagia• Polyuria• Retinopathy• Type 1 diabetes mellitus• Type 2 diabetes mellitus

Page 4: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

What is the Purpose ofAntidiabetic &

Hypoglycemic Agents?

•Treat Diabetes•Lower Blood Sugar

Page 5: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

ANTIDIABETIC & HYPOGYLCEMIC AGENTS

•Insulin•Oral Agents

Page 6: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Endogenous Insulin

• Protein Hormone• Secreted Beta Cells-

Pancreas• 1-2 Units per hour• 4-6 Units per meal

– 1 units x 24hrs + – 4 units x 3 meals

•Total 36 Units per day

Page 7: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

What Does Insulin Do?

•Metabolism of Carbohydrates, Fats, Protein

Page 8: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Pancreas

• Endocrine

• Exocrine

• Islands of Langerhans secretes 3 hormones:– Glucagon (alpha cells)– Insulin (beta cells)– Delta cells - somatostatin

Page 9: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.
Page 10: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Normal Insulin Production

• Pancreas releases insulin into the bloodstream

• Blood carries it to all cells in the body

Page 11: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Normal Insulin Profiles

and a background level of insulin and extra insulin is needed

After a meal

Just to function normally

the blood sugar risesthe body needs a constant level of sugar in the blood

Basic Requirements What happenswhen you eat

Page 12: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Normal Insulin Profiles

Mealtime insulin

Background insulin

Blood sugar

Daily Requirements

Breakfast Lunch Evening Meal

Page 13: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Insulin

Lowers Blood Sugar•Decreases breakdown of glycogen in the liver

Page 14: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Insulin

Decreases the breakdown of fat to fatty acids in adipose tissue

Page 15: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Insulin

Decreases protein breakdown in muscle

Page 16: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Exogenous Insulin

•Commercial Insulin–Has the same effect as endogenous insulin

Page 17: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Normoglycemia!!!

• We are trying to mimic action of pancreas by giving Commercial Insulin (Exogenous Insulin) in clients who cannot produce their own insulin!!!!!

Page 18: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

What Type of Patient Requires Exogenous

Insulin?• Patients who’s Beta Cells become

– Overwhelmed: Disease– Exhausted: Stress or Drugs– Destroyed: Virus, Cancer

Page 19: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Type 1 Diabetes Mellitus Etiology

•Results from an autoimmune disorder that destroys pancreatic beta cells

•Also called Insulin Dependent Diabetes Mellitus IDDM

Page 20: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Type 1 Diabetes Signs and Symptoms

•Disorder of Carbohydrate Metabolism–Glucosuria–Polydipsia–Polyuria–Polyphagia

Page 21: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Insulin Treatment

• Insulin preparations– Onset of action– Duration of action– Degree of purity– Source

Page 22: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Insulin PreparationsAll insulin in UK is 100 units/ml

• Short Acting– Regular- Humulin RALWAYS USED FOR

SLIDING SCALE COVERAGE!!!!!!

• Intermediate Acting– NPH-Humulin N

• Mixtures– 70/30= 70 Units NPH &

30 Units Regular

• Long Acting– Lantus

Page 23: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Short-Acting Insulin

• Soluble

• Clear

• Onset 30 minutes

• Peak 1 - 3 hours

• Duration up to 8 hours

Page 24: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Intermediate Acting Insulin

• Crystals in suspension (need re-suspending)

• Cloudy• NPH or Isophane (NPH = Neutral Protamine

Hagedorn)

• Onset 1 1/2 hours

• Peak 4 - 12 hours• Duration up to 24 hours

Page 25: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.
Page 26: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.
Page 27: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Pre-mixed Insulin

• Pre-mixed combinations of short and intermediate acting insulins (biphasic)

• Cloudy (needs re-suspending)• 5 different combinations (10, 20, 30, 40, 50)

– e.g. 30/70 Mixture = 30% fast acting + 70% intermediate acting

• Onset 30 minutes• Peak 2 - 8 hours• Duration up to 24 hours

Page 28: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Long-Acting InsulinGlargine (Lantus)

Synthetic Human Insulin– Do not mix with any

other insulin– Long Acting Up to 24

hours– NO PEAK– Given at BEDTIME

Page 29: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Species of Insulin

• Human - Genetically engineered using eitheryeast (pyr) or e.coli (prb)

• Animal

– Beef - Increased incidence of allergic problems

– Pork - Less antigenic than beef (Kurtz et al. 1980)

- Available as purified insulin

Page 30: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Storage of Insulin

• Before use Store in fridge

• In-use vials Store in fridge (3 months)

Out of fridge at max 25 C

(4-6 weeks)

• In-use pens Out of fridge at max 25 C (4 weeks)

Page 31: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Insulin Delivery• Insulin devices (pens)

– Durable (replace insulin cartridge)

– Disposable (no need to replace cartridge)

• Insulin vials and syringes

Page 32: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Insulin Devices

Advantages• Improved dose accuracy

• More convenient

– Easy to use

– Portable

– Quick and discreet

• May improve client self-management/compliance

• Preferred by patients

Disadvantages• Cannot mix insulin in a

free-mixing regimen

Page 33: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Who is a good candidate for an Insulin Pump?

Page 34: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Insulin Pumps

• Continuous subcutaneous insulin infusion (CSII)• Battery operated• Programmable computer• Basal insulin throughout day• Bolus insulin before meals• Needles/catheters changed

every 2-3 days

Page 35: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Effects of EXERCISE on Blood Glucose

• By increasing the uptake of glucose by body muscles, exercise does what to Blood Glucose?

Lowers it by

increasing the

number of insulin

receptors!!!!

Page 36: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Effects of ILLNESS on Blood Glucose

• Fever• Flu• Infections• N & V• Surgery• Sunburn

Page 37: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Being sick usually makes blood sugar HIGH!

• Stress increases Blood Glucose

• Never OMIT normally ordered insulin!!!

Page 38: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Interventions for ILLNESS

• Check Blood Glucose q4 hr >240? Check for ketones!!!

• Ketones: call MD!!!!• Sick Day Guidelines…

Page 39: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

DIABETES COMPARISONTYPE 1 TYPE 2

• Autoimmune Process: Beta cells destroyedInsulin deficiency

• Has no insulin• Idiopathic• Genetic predisposition• < Age 30

• Insulin resistancehas some insulin

• Obesity is risk factor• Physical inactivity• Genetic predisposition• Adult onset

Page 40: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Type 2 DiabetesEtiology

• There is abnormally high level of glucose

• Pancreas does produce insulin

• Body resists the insulin’s effects

Page 41: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

As a result, the glucose circulating cannot enter the cells, so that the

glucose cannot be used for energy!!!!!!

Therefore, there is

INSULIN RESISTANCE!!!

Page 42: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Insulin is like the key thatcannot get fit into the lock

(cells)!!!!

Page 43: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

MedicationsAging

INSULIN RESISTANCE

Atherosclerosis

Genetics

Obesity and inactivity

Raredisorders

PCOS

Dyslipidemia

Hypertension

Type 2diabetes

Insulin Resistance: Causes and Associated Conditions

©1998 PPS

C

Page 44: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Type 2 DiabetesSigns and Symptoms

• Hyperglycemia

• Polyuria

• Polydipsia

• Blurred vision

• Fatigue

• Paresthesias

• Skin infections

Page 45: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Type 2 Diabetes

• 80% are obese• 10% non-obese• 10% unstable: may

look more like a Type 1 Diabetic

Page 46: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Oral Agents

•Sulfonylureas

•Biguanides

•Glitazones

Page 47: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Sulfonylureas

•Increase secretion of insulin in the pancreas

Page 48: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Sulfonylureas Side Effects

•Hematologic effects

•GI effects•Hypoglycemia

Page 49: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Biguanides

•Increase the use of glucose by muscles and fat cells

Page 50: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

BiguanidesSide Effects

• GI• Metallic Taste• Decreased Vitamin

B12• Rare Lactic Acidosis• DOES NOT CAUSE

Hypoglycemia

Page 51: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Glitazones

•Decrease Insulin Resistance –Stimulate receptors on muscle, fat and liver cells

– Increase effectiveness of circulating insulin

Page 52: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

GlitazonesSide Efects

•Weight Gain•Hepatic Toxicity

Page 53: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Nursing Assessment for All Diabetic Clients

• What time will the insulin/oral agent act?

• What carbohydrates are available?

• Observe for Therapeutic Effects

• What are the Adverse Effects?

Page 54: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Lab Assessment for All Diabetic Clients

• Blood tests 1. Fasting Blood Glucose Test (Cavenaugh pg. 105) 2. Blood Glucose Monitor Systems 2. Oral Glucose Tolerance Test (Cavenaugh pg. 109) 3. Glycosylated Hemoglobin Assays (Cavenaugh pg. 112) 4. Glycosylated Serum Proteins and Albumin (Cavenaugh pg. 114)

Page 55: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Checking Blood Glucose

• CBGs

• AccuChecks

• Glucometer

• Glucoscan

Page 56: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Hemoglobin A1c

• A blood test that shows glucose levels for the past 3 months

• No preparation needed i.e. fasting, etc.

Page 57: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Values for HbA1c

• Non-diabetic <6 %

• Diabetic with good control <7 %

• Diabetic out of control >8 %

Page 58: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

ADA Treatment Goals

• Hgb A1C maintained at 7% or below

• Premeal blood glucose level 70 to 110mg/dl

• Blood glucose at bedtime 100-140mg/dl

Page 59: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

0

5

10

15

20

25

0

5

10

15

20

25

CHD mortalityIncidence (%) in 3.5 years

All CHD eventsIncidence (%) in 3.5 years

HbA1c HbA1c

Low<6%

Middle6-7.9%

High>7.9%

Low<6%

Middle6-7.9%

High>7.9%

HbA1c Predicts CHD in Type 2

Page 60: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Client Teaching related to Antidiabetic &

Hypoglycemic Therapy• Observe for Therapeutic

Effects• Observe for Adverse

Effects• Observe Injection Site

• Signs of Hypoglycemia• (see handout)• Nursing Interventions

• Signs of Hyperglycemia• (see handout)• Nursing Interventions

Page 61: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.
Page 62: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Management of Hypoglycemia

• Hypoglycemic protocol1. Mild hypoglycemia (BG < 60 and symptomatic)

- 10 to 15g of carbohydrate

- Recheck BG in 15minutes

2. Moderate (BG < 40 and symptomatic)

-15 to 30g of rapidly absorbed CHO

3. Severe (BG < 20 and unable to swallow)

- 1mg of glucagon IM/SQ or amp of D50 IVP

Page 63: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.
Page 64: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Treatment for DKA

• Frequent assessment of client: LOC, V/S, blood glucose levels, fluid and electrolyte status

• Correct fluid volume deficit1. 1 liter of isotonic saline over 1 hour 2. 1 liter of hypotonic saline over 6 to 8 hrs3. 1 liter of hypertonic solution (D51/2NS) over

8 to 12 hrs.

Page 65: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

Drug therapy for DKA

• Insulin therapy: lower BG by 75-150mg/dl/hr1. Regular insulin IV bolus dose of .1u/kg followed by

IV drip of .1u/kg/hr.

2. SQ insulin when client can eat and ketosis has ended.

• Electrolyte replacement1. Potassium

2. Bicarbonate

Page 66: Antidiabetic and Hypoglycemic Agents Lilley Pharmacology Text: Chapter 30 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed., Professor of Nursing.

THE END!!!!